πŸ‡ΊπŸ‡Έ FDA

Intelligence Platform

Patents

Browse 2,432 pharma-relevant patents (US and EP, A61K/A61P) linked to tracked companies. Patent cliff and LOE intelligence for BD teams.

29,054 patents indexed
patent

US 9856262

Analogues of 4H-pyrazolo[1,5-a] benzimidazole compound as PARP inhibitors

Medshine Discovery Inc. Β· Granted Tue Jan 02 2018 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Dec 28 2037 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 9850207

Substituted piperidines as soluble epdxide hydrolase inhibitors

The Regents of the University of California Β· Granted Tue Dec 26 2017 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Dec 21 2037 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 9849109

Autotaxin inhibitors and uses thereof

AMIRA PHARMACEUTICALS, INC. Β· Granted Tue Dec 26 2017 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Dec 21 2037 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 9845332

Neprilysin inhibitors

Theravance Biopharma R&D IP, LLC Β· Granted Tue Dec 19 2017 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Dec 14 2037 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 9839639

Neprilysin inhibitors

Theravance Biopharma R&D IP, LLC Β· Granted Tue Dec 12 2017 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Dec 07 2037 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 9840520

Heterocyclic hydroxamic acids as protein deacetylase inhibitors and dual protein deacetyla

The Regents of the University of Colorado, a Body Corporate Β· Granted Tue Dec 12 2017 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Dec 07 2037 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 9840460

Neprilysin inhibitors

Theravance Biopharma R&D IP, LLC Β· Granted Tue Dec 12 2017 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Dec 07 2037 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 9833457

Tricyclic compounds as modulators of TNF-Ξ± synthesis and as PDE4 inhibitors

VTV THERAPEUTICS LLC Β· Granted Tue Dec 05 2017 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Nov 30 2037 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 9834568

Kinase inhibitors and their uses

Rigel Pharmaceuticals, Inc. Β· Granted Tue Dec 05 2017 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Nov 30 2037 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 9828367

Neprilysin inhibitors

Theravance Biopharma R&D IP, LLC Β· Granted Tue Nov 28 2017 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Nov 23 2037 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 9828373

2-amino-pyrido[2,3-D]pyrimidin-7(8H)-one derivatives as CDK inhibitors and uses thereof

SUNSHINE LAKE PHARMA CO., LTD. Β· Granted Tue Nov 28 2017 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Nov 23 2037 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 9828352

Phenyl carbamates and their use as inhibitors of the fatty acid amide hydrolase (FAAH) enz

The Regents of the University of California Β· Granted Tue Nov 28 2017 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Nov 23 2037 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 9822068

Inhibitors of fatty acid amide hydrolase (FAAH) enzyme with improved oral bioavailability

The Regents of the University of California Β· Granted Tue Nov 21 2017 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Nov 16 2037 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 9815796

Pyrimidone carboxamide compounds as PDE2 inhibitors

MSD R&D (China) Co. Ltd. Β· Granted Tue Nov 14 2017 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Nov 09 2037 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 9808458

Plasmodial surface anion channel inhibitors for the treatment or prevention of malaria

The United States of America, as represented by the Secretary, Department of Health and Human Services Β· Granted Tue Nov 07 2017 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Nov 02 2037 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 9809588

GLS1 inhibitors for treating disease

The Board of Regents of the University of Texas System Β· Granted Tue Nov 07 2017 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Nov 02 2037 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 9808459

Inhibitors of influenza viruses replication

Vertex Pharmaceuticals Incorporated Β· Granted Tue Nov 07 2017 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Nov 02 2037 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 9809541

LSD1 inhibitors

Mirati Therapeutics, Inc. Β· Granted Tue Nov 07 2017 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Nov 02 2037 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 9803202

Oligonucleotide-based inhibitors comprising locked nucleic acid motif

MIRAGEN THERAPEUTICS, INC. Β· Granted Tue Oct 31 2017 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Oct 26 2037 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 9801863

Inhibitors of short-chain dehydrogenase activity for modulating hematopoietic stem cells a

The Board of Regents of the University of Texas System Β· Granted Tue Oct 31 2017 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Oct 26 2037 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 9802949

Fused ring compounds as hepatitis C virus inhibitors, pharmaceutical compositions and uses

SUNSHINE LAKE PHARMA CO., LTD. Β· Granted Tue Oct 31 2017 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Oct 26 2037 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 9802904

Inhibitors of the USP1/UAF1 deubiquitinase complex and uses thereof

The United States of America, as represented by the Secretary, Department of Health and Human Services Β· Granted Tue Oct 31 2017 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Oct 26 2037 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 9796664

Compositions including 6-aminohexanoic acid derivatives as HDAC inhibitors

BIOMARIN PHARMACEUTICAL INC. Β· Granted Tue Oct 24 2017 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Oct 19 2037 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 9796671

Aurora kinase inhibitors

Regents of the University of Minnesota Β· Granted Tue Oct 24 2017 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Oct 19 2037 00:00:00 GMT+0000 (Coordinated Universal Time)

granted